The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance

ABSTRACT Kabuki syndrome (KS) is caused by mutations in KMT2D, which is a histone methyltransferase involved in methylation of H3K4, a histone marker associated with DNA methylation. Analysis of >450,000 CpGs in 24 KS patients with pathogenic mutations in KMT2D and 216 controls, identified 24 genomic regions, along with 1,504 CpG sites with significant DNA methylation changes including a number of Hox genes and the MYO1F gene. Using the most differentiating and significant probes and regions we developed a “methylation variant pathogenicity (MVP) score,” which enables 100% sensitive and specific identification of individuals with KS, which was confirmed using multiple public and internal patient DNA methylation databases. We also demonstrated the ability of the MVP score to accurately reclassify variants of unknown significance in subjects with apparent clinical features of KS, enabling its potential use in molecular diagnostics. These findings provide novel insights into the molecular etiology of KS and illustrate that DNA methylation patterns can be interpreted as ‘epigenetic echoes’ in certain clinical disorders.

[1]  C. Skinner,et al.  Clinical Validation of a Genome-Wide DNA Methylation Assay for Molecular Diagnosis of Imprinting Disorders. , 2017, The Journal of molecular diagnostics : JMD.

[2]  Andrei L. Turinsky,et al.  CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions , 2017, American journal of human genetics.

[3]  C. Skinner,et al.  Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome , 2017, Epigenetics & Chromatin.

[4]  G. Paré,et al.  The defining DNA methylation signature of Floating-Harbor Syndrome , 2016, Scientific Reports.

[5]  V. Siu,et al.  Constitutional Epi/Genetic Conditions: Genetic, Epigenetic, and Environmental Factors , 2016, Journal of Pediatric Genetics.

[6]  C. Skinner,et al.  Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array. , 2016, The Journal of molecular diagnostics : JMD.

[7]  G. Paré,et al.  Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy , 2016, Clinical Epigenetics.

[8]  T. Meitinger,et al.  Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X‐Linked Kabuki Syndrome Subtype 2 , 2016, Human mutation.

[9]  G. Paré,et al.  DNA methylation analysis in constitutional disorders: Clinical implications of the epigenome , 2016, Critical reviews in clinical laboratory sciences.

[10]  H. Bjornsson.  The Mendelian disorders of the epigenetic machinery , 2015, Genome research.

[11]  J. Ko,et al.  Kabuki syndrome: clinical and molecular characteristics , 2015, Korean journal of pediatrics.

[12]  Kurt Hornik,et al.  Misc Functions of the Department of Statistics, ProbabilityTheory Group (Formerly: E1071), TU Wien , 2015 .

[13]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[14]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[15]  R. Klose,et al.  Understanding the relationship between DNA methylation and histone lysine methylation , 2014, Biochimica et biophysica acta.

[16]  H. Bjornsson,et al.  Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states. , 2014, Annual review of genomics and human genetics.

[17]  Martin J. Aryee,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[18]  Hyun-Seok Jin,et al.  Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome , 2014, Journal of Human Genetics.

[19]  Min Gyu Lee,et al.  UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells. , 2014, Cancer research.

[20]  G. Scarano,et al.  Molecular Analysis, Pathogenic Mechanisms, and Readthrough Therapy on a Large Cohort of Kabuki Syndrome Patients , 2014, Human mutation.

[21]  B. Wollnik,et al.  Unmasking Kabuki syndrome , 2013, Clinical genetics.

[22]  R. Weksberg,et al.  Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.

[23]  R. McLendon,et al.  Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways , 2012, Proceedings of the National Academy of Sciences.

[24]  Jeffrey T Leek,et al.  Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. , 2012, International journal of epidemiology.

[25]  S. Mandal,et al.  HOXC6 Is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment. , 2011, Journal of molecular biology.

[26]  F. Fuks,et al.  Regulation of mammalian DNA methyltransferases: a route to new mechanisms , 2011, EMBO reports.

[27]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[28]  Max Kuhn,et al.  Building Predictive Models in R Using the caret Package , 2008 .

[29]  I. Issaeva,et al.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development , 2007, Nature.

[30]  Howard Y. Chang,et al.  A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.

[31]  Daniel Chourrout,et al.  Genome Regulation by Polycomb and Trithorax Proteins , 2007, Cell.

[32]  C. Croce,et al.  Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth , 2006, Molecular and Cellular Biology.

[33]  Xing Zhang,et al.  The SET-domain protein superfamily: protein lysine methyltransferases , 2005, Genome Biology.

[34]  N. Niikawa,et al.  Kabuki make‐up syndrome: A review , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[35]  C. Croce,et al.  Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax , 1997, Oncogene.

[36]  N. Holder,et al.  Retinoic acid modifies development of the midbrain-hindbrain border and affects cranial ganglion formation in zebrafish embryos. , 1991, Development.

[37]  X. Estivill,et al.  Are MYO1C and MYO1F associated with hearing loss? , 2009, Biochimica et biophysica acta.